MetLife Investment Management, LLC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 156 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$367,502
-17.7%
22,3270.0%0.00%0.0%
Q2 2023$446,317
+5.7%
22,3270.0%0.00%0.0%
Q1 2023$422,204
-16.6%
22,3270.0%0.00%
-25.0%
Q4 2022$506,376
-17.6%
22,327
-4.0%
0.00%
-20.0%
Q3 2022$614,815
+17.6%
23,262
+9.9%
0.01%
+25.0%
Q2 2022$522,800
-32.9%
21,166
-9.9%
0.00%
-20.0%
Q1 2022$779,699
+56.9%
23,492
+54.6%
0.01%
+25.0%
Q4 2021$496,942
-22.0%
15,1970.0%0.00%
-33.3%
Q3 2021$637,058
+7.9%
15,1970.0%0.01%0.0%
Q2 2021$590,403
+13.9%
15,1970.0%0.01%
+20.0%
Q1 2021$518,370
-24.8%
15,1970.0%0.01%
-28.6%
Q4 2020$689,336
+64.8%
15,1970.0%0.01%
+40.0%
Q3 2020$418,221
-25.3%
15,1970.0%0.01%
-16.7%
Q2 2020$559,706
+13.7%
15,1970.0%0.01%
-14.3%
Q1 2020$492,079
-21.0%
15,1970.0%0.01%
+16.7%
Q4 2019$622,621
+15.1%
15,1970.0%0.01%0.0%
Q3 2019$541,013
-30.7%
15,1970.0%0.01%
-33.3%
Q2 2019$780,669
-3.3%
15,197
+7.8%
0.01%0.0%
Q1 2019$807,670
+36.6%
14,0930.0%0.01%
+28.6%
Q4 2018$591,201
-44.4%
14,0930.0%0.01%
-36.4%
Q3 2018$1,064,022
+12.2%
14,093
+6.6%
0.01%0.0%
Q2 2018$948,000
+140.0%
13,2170.0%0.01%
+120.0%
Q1 2018$395,000
-10.0%
13,2170.0%0.01%0.0%
Q4 2017$439,00013,2170.01%
Other shareholders
REGENXBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders